Indicated to the treatment of pediatric sufferers who may have growth failure resulting from an insufficient secretion of endogenous growth hormone (GH). GENOTROPIN is contraindicated in patients by using a recognised hypersensitivity to somatropin or any of its excipients. Major systemic hypersensitivity reactions such as anaphylactic reactions and angioedema are https://stearnsc210pfv8.wikicorrespondent.com/user